Login to Your Account

EMA's SME Office Highlights Positive Drug Approval Trends

By Nuala Moran
Staff Writer

Tuesday, February 26, 2013
LONDON – Biotechs registered with the SME (small- and medium-sized enterprise) Office of the European Medicines Agency (EMA) have seen consistent improvements in the success rate of applications for marketing approvals, according to a report analyzing activity in the seven years since the office was set up in 2005.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription